Cargando…

Correlation between serum cytokines and clinicopathological features in patients with drug-induced liver injury

Objectives: Changes in serum levels of cytokines have been proposed as possible biological markers of tissue damage, including drug-induced liver injury (DILI). Here, we aimed to screen cytokine markers that have guiding significance for the degree of inflammation of DILI. Patients and methods: 54 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yu, Gao, Hui, Shao, Yue-Ming, Zhang, Rui-Hua, Wen, Xiao-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773069/ https://www.ncbi.nlm.nih.gov/pubmed/36569295 http://dx.doi.org/10.3389/fphar.2022.1070802

Ejemplares similares

Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
por: Zhou, Zhi-Xuan, et al.
Publicado: (2022)

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
por: Guo, Rong-Hong, et al.
Publicado: (2022)

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury
por: Zeng, Zhan, et al.
Publicado: (2022)

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
por: Li, Xichuan, et al.
Publicado: (2022)

Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of Polygonum multiflorum in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis
por: Li, Chun-Yu, et al.
Publicado: (2016)

Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
por: Shao, Qihui, et al.
Publicado: (2021)

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
por: Cheng, Fang, et al.
Publicado: (2023)

Screening for Susceptibility-Related Factors and Biomarkers of Xianling Gubao Capsule-Induced Liver Injury
por: Li, Chun-yu, et al.
Publicado: (2020)

Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010–2019)
por: Ke, Lixin, et al.
Publicado: (2020)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury
por: Xiong, Yu-Ting, et al.
Publicado: (2023)

The Study on the Mechanism of Hugan Tablets in Treating Drug-Induced Liver Injury Induced by Atorvastatin
por: Lv, Shujing, et al.
Publicado: (2021)

Deciphering the Underlying Mechanisms of Formula Le-Cao-Shi Against Liver Injuries by Integrating Network Pharmacology, Metabonomics, and Experimental Validation
por: Zhao, Qing, et al.
Publicado: (2022)

Beware of the Potential Risks for Polygoni Multiflori Caulis-Induced Liver Injury
por: Kong, Wei-Song, et al.
Publicado: (2022)

Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic study
por: Dong, Qin, et al.
Publicado: (2015)

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
por: He, Xian, et al.
Publicado: (2022)

Spectrum effect correlation of yangyin tongnao granules on cerebral ischemia-reperfusion injury rats
por: Zhang, Yangyang, et al.
Publicado: (2022)

Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury
por: Dong, Huiqun, et al.
Publicado: (2022)

The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis
por: Meng, Yu-Fan, et al.
Publicado: (2023)

Susceptibility-Related Factor and Biomarkers of Dietary Supplement Polygonum multiflorum-Induced Liver Injury in Rats
por: Tu, Can, et al.
Publicado: (2019)

Epigallocatechin Gallate During Dietary Restriction — Potential Mechanisms of Enhanced Liver Injury
por: Shi, Zhuo, et al.
Publicado: (2021)

Exploration of the Specific Pathology of HXMM Tablet Against Retinal Injury Based on Drug Attack Model to Network Robustness
por: Xi, Yujie, et al.
Publicado: (2022)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
por: Lu, Yifei, et al.
Publicado: (2022)

Serum Metabolomics Coupling With Clinical Laboratory Indicators Reveal Taxonomic Features of Leukemia
por: Xiong, Hao-, et al.
Publicado: (2022)

Puerarin Prevents Acute Liver Injury via Inhibiting Inflammatory Responses and ZEB2 Expression
por: Yang, Junfa, et al.
Publicado: (2021)

The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice
por: Li, Jian, et al.
Publicado: (2019)

Modulation of HMGB1 Release in APAP-Induced Liver Injury: A Possible Strategy of Chikusetsusaponin V Targeting NETs Formation
por: Liu, Jian, et al.
Publicado: (2021)

Poria Attenuates Idiosyncratic Liver Injury Induced by Polygoni Multiflori Radix Praeparata
por: Gao, Dan, et al.
Publicado: (2016)

Therapeutic Drug Monitoring of Ceftazidime-Avibactam Concentrations in Carbapenem-Resistant K. pneumoniae-Infected Patients With Different Kidney Statuses
por: Teng, Xin-Qi, et al.
Publicado: (2022)

Allium victorialis L. Extracts Promote Activity of FXR to Ameliorate Alcoholic Liver Disease: Targeting Liver Lipid Deposition and Inflammation
por: Cui, Zhen-Yu, et al.
Publicado: (2021)

Puerarin: A protective drug against ischemia-reperfusion injury
por: Gao, Minglang, et al.
Publicado: (2022)

Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines
por: Zhu, Wenfang, et al.
Publicado: (2022)

Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response
por: Li, Zhe-Zhen, et al.
Publicado: (2016)

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury
por: Zhou, Yitian, et al.
Publicado: (2019)

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)

Chronic Drug-Induced Liver Injury: Updates and Future Challenges
por: Wang, Qiaoling, et al.
Publicado: (2021)

Expressions of Fib, IL-12 in Serum of Neonatal Necrotizing Enterocolitis and Their Correlation with Clinicopathological Features
por: YIN, Yiyu, et al.
Publicado: (2020)

The effect of ginsenosides on liver injury in preclinical studies: a systematic review and meta-analysis
por: Bian, Xing-Bo, et al.
Publicado: (2023)

Protective Effects and Mechanisms of Polyethylene Glycol Loxenatide Against Hyperglycemia and Liver Injury in db/db diabetic Mice
por: Zhang, Yu, et al.
Publicado: (2021)

Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury
por: Yang, Ruiyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8pjub0scg3ddi4voku5h52j76a